Financial Gravity Asset Management’s Pacira BioSciences PCRX Stock Holding History

Financial Gravity Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$54K	Buy	204 +1	+0.5%	+$42	0.04%	603
2019 Q3	$8K	Hold	203	–	–	0.01%	641
2019 Q2	$9K	Buy	203 +3	+2%	+$127	0.01%	621
2019 Q1	$7K	Buy	+200	New	+$7.81K	0.01%	630
2018 Q3	$10K	Buy	+200	New	+$8.64K	0.01%	578

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Financial Gravity Asset Management's PCRX Position: Q4 2019 in Review

Financial Gravity Asset Management increased its Pacira BioSciences (PCRX) stake by 0.49% in Q4 2019, buying an estimated $42 and bringing the position to 204 shares worth $54K. The position accounts for 0.04% of the portfolio, ranked #603.

Financial Gravity Asset Management first reported a position in PCRX in Q3 2018 and has held it in 5 quarters since. 231 funds tracked by Wall St. Rank hold PCRX as of Q4 2019.

Financial Gravity Asset Management held 204 shares of Pacira BioSciences worth $54K as of Q4 2019.
Financial Gravity Asset Management bought 1 Pacira BioSciences share in Q4 2019, an estimated $42.
Pacira BioSciences made up 0.04% of Financial Gravity Asset Management's portfolio in Q4 2019, its #603 holding.
Financial Gravity Asset Management first reported a position in Pacira BioSciences in Q3 2018 and has held it in 5 quarters since.
231 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.